275 related articles for article (PubMed ID: 21311112)
1. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
Araya N; Takahashi K; Sato T; Nakamura T; Sawa C; Hasegawa D; Ando H; Aratani S; Yagishita N; Fujii R; Oka H; Nishioka K; Nakajima T; Mori N; Yamano Y
Antivir Ther; 2011; 16(1):89-98. PubMed ID: 21311112
[TBL] [Abstract][Full Text] [Related]
2. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
3. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
4. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
Ramirez E; Cartier L; Torres M; Barria M
J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
[TBL] [Abstract][Full Text] [Related]
5. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
[TBL] [Abstract][Full Text] [Related]
6. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
[TBL] [Abstract][Full Text] [Related]
7. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
Carod-Artal FJ
Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
[TBL] [Abstract][Full Text] [Related]
9. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers.
Mori S; Mizoguchi A; Kawabata M; Fukunaga H; Usuku K; Maruyama I; Osame M
Thorax; 2005 Feb; 60(2):138-43. PubMed ID: 15681503
[TBL] [Abstract][Full Text] [Related]
11. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
12. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
[TBL] [Abstract][Full Text] [Related]
13. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
[TBL] [Abstract][Full Text] [Related]
14. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
[TBL] [Abstract][Full Text] [Related]
15. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
16. Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva.
Lins L; de Carvalho VJ; de Almeida Rego FF; Azevedo R; Kashima S; Gallazi VN; Xavier MT; Galvão-Castro B; Alcantara LC
J Med Virol; 2012 Sep; 84(9):1428-36. PubMed ID: 22825822
[TBL] [Abstract][Full Text] [Related]
17. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
18. Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population.
Deschamps R; Béra O; Belrose G; Lezin A; Bellance R; Signate A; Cabre P; Smadja D; Césaire R; Olindo S
Int J Infect Dis; 2010 Nov; 14(11):e986-90. PubMed ID: 20851016
[TBL] [Abstract][Full Text] [Related]
19. Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load.
Castro-Lima Vargens C; Grassi MF; Boa-Sorte N; Rathsam-Pinheiro RH; Olavarria VN; de Almeida Kruschewsky R; Galvão-Castro B
J Clin Virol; 2011 Nov; 52(3):177-80. PubMed ID: 21868282
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]